Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET.
Kaiser L, Quach S, Zounek AJ, Wiestler B, Zatcepin A, Holzgreve A, Bollenbacher A, Bartos LM, Ruf VC, Böning G, Thon N, Herms J, Riemenschneider MJ, Stöcklein S, Brendel M, Rupprecht R, Tonn JC, Bartenstein P, von Baumgarten L, Ziegler S, Albert NL.
Kaiser L, et al. Among authors: bollenbacher a.
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2371-2381. doi: 10.1007/s00259-024-06654-5. Epub 2024 Feb 24.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 38396261
Free PMC article.